Indeed, HGF is a well-recognized proangiogenic mediator which inhibition reduces tumor growth and metastasis [48], as well HIF-1α, which is associated with poor prognosis in cancer due stimulation of VEGFR+ cells migration to the tumor [49]. The gene discussed is HGF; the disease is cancer.